The drug information sheets that the FDA requires companies to produce are living documents that get updated with new ...
Merck & Co. has struck a $9.2 billion deal to buy biotechnology company Cidara Therapeutics in a move that bolsters the ...
The FDA's push for lower-cost medicines looks good on paper, but the patent office under President Trump may be going in the ...
The U.S. Food and Drug Administration can approve new personalized treatments for rare and deadly genetic diseases based on ...
Merck ( MRK) to acquire Cidara Therapeutics ( CDTX) for $221.50 per share in cash, for a total transaction value of ...
Merck will acquire Cidara Therapeutics in a nearly $9.2 billion deal, the companies said on Friday, gaining access to an experimental drug for flu prevention.
NEW DELHI, (Reuters) -The drug company Viatris announced on December 23 that the U.S. Food and Drug Administration (FDA) has restricted imports of 11 products made at its facility in Indore, following ...
The U.S. Food and Drug Administration (FDA) has traditionally refrained from considering drug pricing — and for good reason. Scientific determinations of whether a regulated product meets the legal ...
Prescription Drug User Fee Act (PDUFA) goal date set for August 28, 2026Garching / Munich, Germany, November 13, 2025 – ITM Isotope Technologies ...
The “plausible mechanism” pathway, outlined by Martin Makary and Vinay Prasad, is designed to help accelerate treatments ...
News-Medical.Net on MSN
Indero announces breakthrough method for early-phase evaluation of topical drugs using quantitative gene expression
Indero is proud to announce the successful completion of an internally funded study that introduces a novel approach to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback